Neumora Therapeutics, Inc. Common Stock
HealthcareNASDAQ:NMRA · NASDAQ Global Select
+$0.00 today
Vol 0.72M · Avg 1.22M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+110.78%
Period High
$3.59
Period Low
$0.73
Latest
$1.78
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Alumis Inc. Common Stock
NASDAQ:ALMS
$2.98B
RAPT Therapeutics, Inc.
RAPT
$959.26M
Lexicon Pharmaceuticals, Inc.
NASDAQ:LXRX
$852.86M
Omeros Corporation
NASDAQ:OMER
$632.20M
4D Molecular Therapeutics, Inc.
NASDAQ:FDMT
$461.60M
Prothena Corporation plc
NASDAQ:PRTA
$431.91M
Autolus Therapeutics plc
NASDAQ:AUTL
$415.18M
Bicycle Therapeutics plc
NASDAQ:BCYC
$281.05M
Fulcrum Therapeutics, Inc.
NASDAQ:FULC
$186.68M
ADC Therapeutics S.A.
NYSE:ADCT
$133.55M
What is the latest NMRA filing?
The latest filing shown is 4 dated May 29, 2026.
How many recent filings does NMRA have?
Intrinsic Alpha currently shows 20 recent filings for NMRA.
Explore More
Continue the stock analysis
Jump to another research area for this company.